Response to: baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO
Publication date: Available online 5 February 2018 Source:Annals of Allergy, Asthma & Immunology Author(s): Allan T. Luskin, Bradley E. Chipps, Thomas B. Casale, Noelle M. Griffin
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου